VNDA
Vanda Pharmaceuticals Inc.
Company overview
- Market capitalization
- $312.59M
- Employees
- 533
- Latest publication
- 2026-09-29
About Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs worldwide. The company's commercial portfolio includes Fanapt for the acute treatment of manic or mixed episodes associated with bipolar I disorder and the treatment of schizophrenia; HETLIOZ to treat non-24-hour sleep-wake disorders and nighttime sleep disturbances; PONVORY to treat relapsing forms of multiple sclerosis; and NEREUSTM for preventing vomiting induced by motion. It also develops Fanapt (iloperidone), a long acting injectable (LAI) formulation for the treatment of schizophrenia and hypertension; BysantiTM (milsaperidone), for the acute treatment of manic or mixed episodes associated with bipolar I disorder, and for the treatment of schizophrenia and major depressive disorder; HETLIOZ (tasimelteon) to treat jet lag disorder, insomnia, pediatric insomnia, delayed sleep phase disorder, and pediatric Non-24; PONVORY (ponesimod) to treat psoriasis and ulcerative colitis; and NEREUSTM (tradipitant) for prevention of vomiting induced by GLP-1 receptor agonists, as well as treatment of gastroparesis and atopic dermatitis. In addition, the company's products include Imsidolimab, an IL-36R antagonist to treat generalized pustular psoriasis; VTR-297, for the treatment of hematologic malignancies and onychomycosis, and several oncology indications; and VQW-765, small molecule alpha-7 nicotinic acetylcholine receptor partial agonist for the treatment of social/performance anxiety and psychiatric disorders. Further, it develops cystic fibrosis transmembrane conductance regulator activators and inhibitors; and antisense oligonucleotide molecules. The company was incorporated in 2002 and is headquartered in Washington, the District of Columbia.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20232023-03-31 · USD | Q4 20222022-12-31 · USD | Q3 20222022-09-30 · USD | Q2 20222022-06-30 · USD | Q4 20212021-12-31 · USD | Q3 20212021-09-30 · USD | Q2 20212021-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 50,529,000USD | 62,498,000USD | 64,482,000USD | 65,318,000USD | 64,390,000USD | 68,019,000USD | 70,095,000USD | 67,899,000USD |
| Cost Of Revenue | 3,560,000USD | 4,774,000USD | 6,238,000USD | 6,320,000USD | 6,059,000USD | 6,236,000USD | 6,797,000USD | 6,566,000USD |
| Gross Profit | 46,969,000USD | 57,724,000USD | 58,244,000USD | 58,998,000USD | 58,331,000USD | 61,783,000USD | 63,298,000USD | 61,333,000USD |
| Research Development | 36,953,000USD | 19,237,000USD | 18,454,000USD | 24,857,000USD | 21,490,000USD | 19,331,000USD | 19,653,000USD | 20,248,000USD |
| Selling General Administrative | 71,838,000USD | 36,104,000USD | 30,182,000USD | 29,854,000USD | 33,001,000USD | 26,747,000USD | 32,456,000USD | 28,347,000USD |
| Other Operating Expenses | 1,987,000USD | — | — | — | — | — | — | — |
| Total Operating Expenses | 110,778,000USD | 55,720,000USD | 51,615,000USD | 55,090,000USD | 54,870,000USD | 53,147,000USD | 52,479,000USD | 48,964,000USD |
| Operating Income | -63,809,000USD | 2,004,000USD | 6,629,000USD | 3,908,000USD | 3,461,000USD | 8,636,000USD | 10,819,000USD | 12,369,000USD |
| Total Other Income Expense Net | 1,425,000USD | 3,524,000USD | 2,984,000USD | 1,553,000USD | 329,000USD | -26,000USD | -97,000USD | 235,000USD |
| Income Before Tax | -62,384,000USD | 5,528,000USD | 9,613,000USD | 5,461,000USD | 3,790,000USD | 8,610,000USD | 10,722,000USD | 12,604,000USD |
| Income Tax Expense | 129,000USD | 2,276,000USD | 2,752,000USD | 2,191,000USD | 1,216,000USD | 1,532,000USD | 2,951,000USD | 2,951,000USD |
| Net Income | -62,513,000USD | 3,252,000USD | 6,861,000USD | 3,270,000USD | 2,574,000USD | 7,078,000USD | 7,771,000USD | 9,653,000USD |
| Interest Expense | — | 3,524,000USD | 2,984,000USD | 1,553,000USD | 329,000USD | — | — | — |
| Tax Provision | — | 2,276,000USD | 2,752,000USD | 2,191,000USD | 1,216,000USD | 1,532,000USD | 2,951,000USD | 2,951,000USD |
| Net Income From Continuing Ops | — | 3,252,000USD | 6,861,000USD | 3,270,000USD | 2,574,000USD | 7,078,000USD | 7,771,000USD | 9,653,000USD |
| Ebit | — | 5,528,000USD | 9,613,000USD | 5,461,000USD | 3,790,000USD | 8,610,000USD | 10,722,000USD | 12,604,000USD |
| Ebitda | — | 6,198,000USD | 10,276,000USD | 6,139,000USD | 4,480,000USD | 9,316,000USD | 11,430,000USD | 13,316,000USD |
| Depreciation And Amortization | — | 670,000USD | 663,000USD | 678,000USD | 690,000USD | 706,000USD | 708,000USD | 712,000USD |
| Reconciled Depreciation | — | 670,000USD | 663,000USD | 678,000USD | 690,000USD | 706,000USD | 708,000USD | 369,000USD |
| Net Income Applicable To Common Shares | — | 3,252,000USD | 6,861,000USD | 3,270,000USD | 2,574,000USD | 7,078,000USD | 7,771,000USD | 9,653,000USD |
| Selling And Marketing Expenses | — | — | 2,600,000USD | — | — | 6,700,000USD | — | — |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD | FY 20132013-12-31 · USD | FY 20122012-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 192,640,000USD | 254,382,000USD | 268,682,000USD | 248,168,000USD | 227,188,000USD | 193,118,000USD | 33,879,000USD | 32,727,000USD |
| Cost Of Revenue | 17,574,000USD | 24,282,000USD | 25,629,000USD | 23,364,000USD | 24,488,000USD | 20,508,000USD | 52,352,000USD | 129,000USD |
| Gross Profit | 192,640,000USD | 230,100,000USD | 243,053,000USD | 224,804,000USD | 202,700,000USD | 172,610,000USD | 33,879,000USD | 32,598,000USD |
| Research Development | 76,823,000USD | 85,770,000USD | 75,363,000USD | 55,577,000USD | 48,649,000USD | 43,594,000USD | 28,190,000USD | 45,446,000USD |
| Selling General Administrative | 122,052,000USD | 133,885,000USD | 117,347,000USD | 127,910,000USD | 126,536,000USD | 105,751,000USD | 24,594,000USD | 13,882,000USD |
| Selling And Marketing Expenses | 500,000USD | 2,600,000USD | 6,700,000USD | 12,600,000USD | 3,200,000USD | 900,000USD | — | — |
| Unclassified Operating Expenses | 7,217,000USD | — | — | — | — | — | 1,495,000USD | 1,495,000USD |
| Total Operating Expenses | 206,592,000USD | 223,771,000USD | 200,888,000USD | 197,565,000USD | 179,890,000USD | 150,872,000USD | 54,279,000USD | 60,823,000USD |
| Operating Income | -13,952,000USD | 6,329,000USD | 42,165,000USD | 27,239,000USD | 22,810,000USD | 21,738,000USD | -20,400,000USD | -28,225,000USD |
| Income Before Tax | 6,339,000USD | 11,300,000USD | 42,364,000USD | 31,655,000USD | 29,028,000USD | 25,346,000USD | -20,255,000USD | -27,664,000USD |
| Income Tax Expense | 3,830,000USD | 5,025,000USD | 9,212,000USD | 8,318,000USD | -86,525,000USD | 138,000USD | 0USD | 0USD |
| Tax Provision | 5,843,000USD | 5,025,000USD | 9,212,000USD | 8,318,000USD | -86,525,000USD | 138,000USD | — | — |
| Net Income | 2,509,000USD | 6,275,000USD | 33,152,000USD | 23,337,000USD | 115,553,000USD | 25,208,000USD | -20,255,000USD | -27,664,000USD |
| Net Income From Continuing Ops | 11,770,000USD | 6,275,000USD | 33,152,000USD | 23,337,000USD | 115,553,000USD | 25,246,000USD | -20,255,000USD | -27,664,000USD |
| Ebit | -13,952,000USD | 11,300,000USD | 42,364,000USD | 31,655,000USD | 22,810,000USD | 21,738,000USD | -20,768,000USD | -28,545,000USD |
| Ebitda | -13,952,000USD | 14,033,000USD | 45,205,000USD | 34,519,000USD | 25,702,000USD | 24,694,000USD | -19,273,000USD | -27,050,000USD |
| Depreciation And Amortization | 3,010,000USD | 2,733,000USD | 2,841,000USD | 2,864,000USD | 2,892,000USD | 2,956,000USD | 1,495,000USD | 1,495,000USD |
| Reconciled Depreciation | 2,515,000USD | 2,733,000USD | 2,841,000USD | 2,864,000USD | 2,892,000USD | 2,956,000USD | — | — |
| Total Other Income Expense Net | 20,291,000USD | 4,971,000USD | 199,000USD | 4,416,000USD | 6,218,000USD | 3,608,000USD | 145,000USD | 1,514,000USD |
| Interest Expense | — | 4,971,000USD | 199,000USD | 4,416,000USD | 6,218,000USD | 0USD | 0USD | 0USD |
| Net Income Applicable To Common Shares | — | 6,275,000USD | 33,152,000USD | 23,337,000USD | 115,553,000USD | 25,208,000USD | -20,255,000USD | -27,664,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 412,467,000USD | 433,525,000USD | 488,948,000USD | 601,140,000USD | 624,746,000USD | 631,936,000USD | 656,204,000USD | 645,115,000USD |
| Cash And Equivalents | 55,882,000USD | — | — | — | — | — | — | — |
| Total Current Assets | 264,484,000USD | 293,169,000USD | 347,262,000USD | 367,496,000USD | 394,921,000USD | 407,910,000USD | 438,890,000USD | 432,387,000USD |
| Other Current Assets | 33,085,000USD | 32,281,000USD | 26,985,000USD | 21,161,000USD | 22,209,000USD | 20,476,000USD | 15,420,000USD | 11,759,000USD |
| Total Liabilities | 192,282,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 164,026,000USD | 135,582,000USD | 145,162,000USD | 117,870,000USD | 121,489,000USD | 103,923,000USD | 99,981,000USD | 89,090,000USD |
| Other Non Current Liabilities | 10,054,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 220,185,000USD | 280,765,000USD | 327,186,000USD | 465,999,000USD | 486,329,000USD | 511,417,000USD | 538,546,000USD | 541,223,000USD |
| Total Equity Including Noncontrolling Interest | 220,185,000USD | — | — | — | — | — | — | — |
| Net Receivables | 59,692,000USD | 56,879,000USD | 54,578,000USD | 50,541,000USD | 44,993,000USD | 44,603,000USD | 47,101,000USD | 42,753,000USD |
| Inventory | 1,678,000USD | 1,699,000USD | 1,852,000USD | 2,042,000USD | 2,169,000USD | 1,923,000USD | 1,726,000USD | 1,614,000USD |
| Property Plant Equipment Net | 17,176,000USD | 14,065,000USD | 13,514,000USD | 11,899,000USD | 12,468,000USD | 12,475,000USD | 12,677,000USD | 8,194,000USD |
| Accounts Payable | 69,994,000USD | 4,472,000USD | 4,940,000USD | 3,140,000USD | 2,181,000USD | 5,990,000USD | 3,498,000USD | 5,809,000USD |
| Common Stock | 60,000USD | 60,000USD | 59,000USD | 59,000USD | 59,000USD | 59,000USD | 58,000USD | 58,000USD |
| Retained Earnings | -505,846,000USD | -443,333,000USD | -394,766,000USD | -253,579,000USD | -230,993,000USD | -203,786,000USD | -174,292,000USD | -169,380,000USD |
| Accumulated Other Comprehensive Income | 38,000USD | 212,000USD | 629,000USD | 540,000USD | 396,000USD | 383,000USD | 74,000USD | 702,000USD |
| Intangible Assets | — | 115,102,000USD | 117,089,000USD | 108,841,000USD | 110,593,000USD | 112,344,000USD | 114,096,000USD | 115,848,000USD |
| Total Liab | — | 152,760,000USD | 161,762,000USD | 135,141,000USD | 138,417,000USD | 120,519,000USD | 117,658,000USD | 103,892,000USD |
| Other Current Liab | — | 125,088,000USD | 134,667,000USD | 110,042,000USD | 114,630,000USD | 93,539,000USD | 92,213,000USD | 80,827,000USD |
| Capital Stock | — | 60,000USD | 59,000USD | 59,000USD | 59,000USD | 59,000USD | 58,000USD | 58,000USD |
| Cash | — | 54,034,000USD | 84,851,000USD | 70,022,000USD | 80,983,000USD | 111,796,000USD | 102,316,000USD | 100,497,000USD |
| Cash And Short Term Investments | — | 202,310,000USD | 263,847,000USD | 293,752,000USD | 325,550,000USD | 340,908,000USD | 374,643,000USD | 376,261,000USD |
| Net Debt | — | -40,961,000USD | -72,229,000USD | -59,107,000USD | -69,345,000USD | -100,051,000USD | -89,956,000USD | -92,557,000USD |
| Short Term Debt | — | 6,022,000USD | 5,555,000USD | 4,688,000USD | 4,678,000USD | 4,394,000USD | 4,270,000USD | 2,454,000USD |
| Short Long Term Debt Total | — | 13,073,000USD | 12,622,000USD | 10,915,000USD | 11,638,000USD | 11,745,000USD | 12,360,000USD | 7,940,000USD |
| Short Term Investments | — | 148,276,000USD | 178,996,000USD | 223,730,000USD | 244,567,000USD | 229,112,000USD | 272,327,000USD | 275,764,000USD |
| Property Plant Equipment Gross | — | 14,065,000USD | 26,130,000USD | 11,899,000USD | 12,468,000USD | 12,475,000USD | 24,244,000USD | 8,194,000USD |
| Common Stock Shares Outstanding | — | 59,459,982shares | 59,098,957shares | 58,873,268shares | 58,993,990shares | 58,527,775shares | 58,308,000shares | 58,262,000shares |
| Non Current Assets Total | — | 140,356,000USD | 141,686,000USD | 233,644,000USD | 229,825,000USD | 224,026,000USD | 217,314,000USD | 212,728,000USD |
| Non Current Liabilities Total | — | 17,178,000USD | 16,600,000USD | 17,271,000USD | 16,928,000USD | 16,596,000USD | 17,677,000USD | 14,802,000USD |
| Non Current Liabilities Other | — | 10,127,000USD | 9,533,000USD | 11,044,000USD | 9,968,000USD | 9,245,000USD | 9,587,000USD | 9,316,000USD |
| Non Currrent Assets Other | — | 10,823,000USD | 11,083,000USD | 9,831,000USD | 9,621,000USD | 10,060,000USD | 9,101,000USD | 9,323,000USD |
| Net Working Capital | — | 157,587,000USD | 202,100,000USD | 249,626,000USD | 273,432,000USD | 303,987,000USD | 338,909,000USD | 343,297,000USD |
| Unclassified Non Current Liabilities | — | 7,051,000USD | 7,067,000USD | 6,227,000USD | 6,960,000USD | 7,351,000USD | 8,090,000USD | 5,486,000USD |
| Unclassified Equity | — | 723,766,000USD | 721,205,000USD | 718,920,000USD | 716,808,000USD | 714,702,000USD | 712,648,000USD | 709,785,000USD |
| Unclassified Non Current Assets | — | — | — | 103,073,000USD | 97,143,000USD | 89,147,000USD | 81,440,000USD | 79,363,000USD |
| Current Deferred Revenue | — | — | — | — | — | — | — | 49,786,000USD |
| Unclassified Current Liabilities | — | — | — | — | — | — | — | -49,786,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 488,948,000USD | 656,204,000USD | 648,440,000USD | 634,247,000USD | 593,792,000USD | 533,456,000USD | 483,748,000USD | 332,130,000USD |
| Intangible Assets | 117,089,000USD | 114,096,000USD | 121,369,000USD | 18,565,000USD | 20,081,000USD | 21,559,000USD | 23,037,000USD | 24,542,000USD |
| Other Current Assets | 26,985,000USD | 15,420,000USD | 9,170,000USD | 17,727,000USD | 11,996,001USD | 10,089,000USD | 14,500,000USD | 11,998,000USD |
| Total Liab | 161,762,000USD | 117,658,000USD | 103,530,000USD | 107,049,000USD | 88,864,000USD | 80,190,000USD | 72,803,000USD | 56,708,000USD |
| Total Stockholder Equity | 327,186,000USD | 538,546,000USD | 544,910,000USD | 527,198,000USD | 504,928,000USD | 453,266,000USD | 410,945,000USD | 275,422,000USD |
| Other Current Liab | 134,667,000USD | 92,213,000USD | 78,154,000USD | 76,418,000USD | 71,183,000USD | 62,770,000USD | 51,454,000USD | 63,064,000USD |
| Common Stock | 59,000USD | 58,000USD | 58,000USD | 57,000USD | 56,000USD | 55,000USD | 54,000USD | 52,000USD |
| Capital Stock | 59,000USD | 58,000USD | 58,000USD | 57,000USD | 56,000USD | 55,000USD | 54,000USD | 52,000USD |
| Retained Earnings | -394,766,000USD | -174,292,000USD | -155,392,000USD | -157,901,000USD | -164,176,000USD | -197,328,000USD | -220,665,000USD | -336,218,000USD |
| Cash | 84,851,000USD | 102,316,000USD | 135,821,000USD | 135,029,000USD | 52,071,000USD | 61,031,000USD | 45,072,000USD | 61,005,000USD |
| Cash And Short Term Investments | 263,847,000USD | 374,643,000USD | 388,264,000USD | 466,859,000USD | 432,813,000USD | 367,740,000USD | 312,129,000USD | 257,360,000USD |
| Total Current Assets | 347,262,000USD | 438,890,000USD | 432,946,000USD | 519,292,000USD | 478,301,000USD | 409,145,000USD | 354,136,000USD | 299,132,000USD |
| Total Current Liabilities | 145,162,000USD | 99,981,000USD | 87,697,000USD | 91,436,000USD | 74,419,000USD | 65,936,000USD | 59,505,000USD | 53,015,000USD |
| Net Debt | -72,229,000USD | -89,956,000USD | -126,417,000USD | -123,888,000USD | -39,705,000USD | -47,417,000USD | -30,470,000USD | -61,005,000USD |
| Short Term Debt | 5,555,000USD | 4,270,000USD | 2,398,000USD | 2,328,000USD | 2,311,000USD | 2,117,000USD | 2,147,000USD | — |
| Short Long Term Debt Total | 12,622,000USD | 12,360,000USD | 9,404,000USD | 11,141,000USD | 12,366,000USD | 13,614,000USD | 14,602,000USD | — |
| Short Term Investments | 178,996,000USD | 272,327,000USD | 252,443,000USD | 331,830,000USD | 380,742,000USD | 306,709,000USD | 267,057,000USD | 196,355,000USD |
| Net Receivables | 54,578,000USD | 47,101,000USD | 34,155,000USD | 33,512,000USD | 32,467,000USD | 30,036,000USD | 26,367,000USD | 28,780,000USD |
| Inventory | 1,852,000USD | 1,726,000USD | 1,357,000USD | 1,194,000USD | 1,024,999USD | 1,280,000USD | 1,140,000USD | 994,000USD |
| Accounts Payable | 4,940,000USD | 3,498,000USD | 7,145,000USD | 12,690,000USD | 925,000USD | 1,049,000USD | 5,904,000USD | 3,640,000USD |
| Property Plant Equipment Net | 13,514,000USD | 12,677,000USD | 9,140,000USD | 10,973,000USD | 12,385,000USD | 14,595,000USD | 15,044,000USD | 4,417,000USD |
| Property Plant Equipment Gross | 26,130,000USD | 24,244,000USD | 20,321,000USD | 10,973,000USD | 12,385,000USD | 4,136,000USD | 15,044,000USD | 4,417,000USD |
| Accumulated Other Comprehensive Income | 629,000USD | 74,000USD | -30,000USD | -1,193,000USD | -175,000USD | 239,000USD | 249,000USD | 1,000USD |
| Common Stock Shares Outstanding | 58,930,157shares | 58,149,000shares | 57,557,911shares | 56,983,171shares | 56,921,836shares | 55,190,802shares | 54,847,060shares | 53,045,257shares |
| Non Current Assets Total | 141,686,000USD | 217,314,000USD | 215,494,000USD | 114,955,000USD | 115,491,000USD | 124,311,000USD | 129,611,999USD | 32,998,000USD |
| Non Current Liabilities Total | 16,600,000USD | 17,677,000USD | 15,833,000USD | 15,613,000USD | 14,445,000USD | 14,254,000USD | 13,297,999USD | 3,693,000USD |
| Non Current Liabilities Other | 9,533,000USD | 9,587,000USD | 8,827,000USD | 15,613,000USD | 14,445,000USD | 14,254,000USD | 13,298,000USD | 3,693,000USD |
| Non Currrent Assets Other | 11,083,000USD | 9,101,000USD | 9,985,000USD | 11,378,000USD | 8,147,000USD | 6,641,000USD | 3,272,999USD | 4,039,000USD |
| Net Working Capital | 202,100,000USD | 338,909,000USD | 345,249,000USD | 427,856,000USD | 403,882,000USD | 343,209,000USD | 294,631,000USD | 246,117,000USD |
| Unclassified Non Current Liabilities | 7,067,000USD | 8,090,000USD | 7,006,000USD | -6,800,000USD | -4,390,000USD | -2,757,000USD | — | -3,693,000USD |
| Unclassified Equity | 721,205,000USD | 712,648,000USD | 700,216,000USD | 686,178,000USD | 669,167,000USD | 650,245,000USD | 631,253,000USD | 611,535,000USD |
| Unclassified Non Current Assets | — | 81,440,000USD | 75,000,000USD | -11,378,000USD | -8,147,000USD | -6,641,000USD | -3,273,000USD | -4,039,000USD |
| Other Liab | — | — | — | 6,800,000USD | 4,390,000USD | 2,757,000USD | 843,000USD | 3,693,000USD |
| Other Assets | — | — | — | 85,417,000USD | 83,025,000USD | 88,157,000USD | 91,531,000USD | 4,039,000USD |
| Net Tangible Assets | — | — | — | 508,633,000USD | 484,847,000USD | 431,707,000USD | 387,908,000USD | 250,880,000USD |
| Current Deferred Revenue | — | — | — | — | — | -5,817,000USD | -5,904,000USD | — |
| Unclassified Current Liabilities | — | — | — | — | — | — | — | -13,689,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -48,567,000USD | -141,187,000USD | -22,586,000USD | -27,207,000USD | -29,494,000USD | -4,912,000USD | -5,324,000USD | -4,518,000USD |
| Depreciation | 3,527,000USD | 5,863,000USD | 2,053,000USD | -2,787,000USD | 1,983,000USD | 1,973,000USD | 1,967,000USD | 1,968,000USD |
| Stock Based Compensation | 2,563,000USD | 2,285,000USD | 2,112,000USD | 2,106,000USD | 2,971,000USD | 2,863,000USD | 2,999,000USD | 2,986,000USD |
| Other Non Cash Items | 144,000USD | -2,590,000USD | 895,000USD | 5,286,000USD | 1,104,000USD | -545,000USD | -1,494,000USD | -1,517,000USD |
| Change To Account Receivables | -2,333,000USD | -4,075,000USD | -5,569,000USD | -353,000USD | 2,534,000USD | -4,431,000USD | -830,000USD | -5,164,000USD |
| Change To Inventory | 294,000USD | -1,280,000USD | 32,000USD | -368,000USD | -1,850,000USD | -107,000USD | -214,000USD | 263,000USD |
| Change In Working Capital | -7,885,000USD | 3,026,000USD | -8,126,000USD | 15,322,000USD | -1,914,000USD | 718,000USD | -9,641,000USD | -4,613,000USD |
| Total Cash From Operating Activities | -50,218,000USD | -29,417,000USD | -31,626,000USD | -15,252,000USD | -33,147,000USD | -1,817,000USD | -14,581,000USD | -6,928,000USD |
| Capital Expenditures | -221,000USD | -102,000USD | -161,000USD | -299,000USD | -436,000USD | -214,000USD | -161,000USD | -108,000USD |
| Free Cash Flow | -50,439,000USD | -29,519,000USD | -31,787,000USD | -15,551,000USD | -33,583,000USD | -2,031,000USD | -14,742,000USD | -7,036,000USD |
| Investments | 30,455,000USD | 44,968,000USD | 21,362,000USD | -15,270,000USD | 43,902,000USD | 3,993,000USD | 12,057,000USD | -15,262,000USD |
| Total Cashflows From Investing Activities | 20,234,000USD | 44,866,000USD | 21,362,000USD | -15,270,000USD | 43,902,000USD | 3,993,000USD | 12,057,000USD | -15,262,000USD |
| Net Borrowings | -776,000USD | -640,000USD | -517,000USD | -425,000USD | -409,000USD | — | — | — |
| Total Cash From Financing Activities | -776,000USD | -640,000USD | -517,000USD | -425,000USD | -1,324,000USD | -155,000USD | — | 0USD |
| Change In Cash | -30,920,000USD | 14,932,000USD | -10,961,000USD | -30,813,000USD | 9,480,000USD | 1,819,000USD | -2,456,000USD | -22,205,000USD |
| Begin Period Cash Flow | 84,954,000USD | 70,491,000USD | 81,452,000USD | 112,265,000USD | 102,785,000USD | 100,497,000USD | 103,422,000USD | 125,627,000USD |
| End Period Cash Flow | 54,034,000USD | 85,320,000USD | 70,491,000USD | 81,452,000USD | 112,265,000USD | 102,316,000USD | 100,966,000USD | 103,422,000USD |
| Unclassified Investing Cash Flow | -10,000,000USD | — | — | — | — | — | 4,390,000USD | 1,632,000USD |
| Unclassified Operating Cash Flow | — | 103,186,000USD | -5,974,000USD | -7,972,000USD | -7,797,000USD | -1,914,000USD | -3,088,000USD | -1,234,000USD |
| Other Cashflows From Financing Activities | — | — | -517,000USD | — | -915,000USD | — | 12,057,000USD | -15,262,000USD |
| Other Cashflows From Investing Activities | — | — | — | — | — | — | -4,229,000USD | -1,524,000USD |
| Unclassified Financing Cash Flow | — | — | — | — | — | — | — | 15,262,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -220,474,000USD | -18,900,000USD | 2,509,000USD | 6,275,000USD | 33,152,000USD | 23,337,000USD | 115,553,000USD | 25,208,000USD |
| Depreciation | -950,000USD | 8,132,000USD | 3,010,000USD | 2,733,000USD | 2,841,000USD | 2,864,000USD | 2,892,000USD | 2,956,000USD |
| Stock Based Compensation | 9,474,000USD | 12,432,000USD | 14,040,000USD | 16,279,000USD | 15,374,000USD | 13,360,000USD | 13,458,000USD | 11,666,000USD |
| Other Non Cash Items | 12,757,000USD | -4,381,000USD | -4,725,000USD | -507,000USD | 3,365,000USD | 1,708,000USD | 12,144,000USD | 167,000USD |
| Change To Account Receivables | -7,463,000USD | -13,012,000USD | -707,000USD | -1,089,000USD | -2,469,000USD | -3,767,000USD | 2,342,000USD | -11,207,000USD |
| Change To Inventory | -3,466,000USD | -29,000USD | -771,000USD | -4,479,000USD | -2,233,000USD | -2,876,000USD | -722,000USD | 70,000USD |
| Change In Working Capital | 8,308,000USD | -6,558,000USD | -747,000USD | 6,074,000USD | 2,737,000USD | 4,317,000USD | 3,125,000USD | -7,790,000USD |
| Total Cash From Operating Activities | -109,442,000USD | -15,757,000USD | 12,801,000USD | 31,984,000USD | 64,214,000USD | 51,775,000USD | 45,947,000USD | 29,986,000USD |
| Capital Expenditures | -998,000USD | -490,000USD | -383,000USD | -679,000USD | -552,000USD | -1,795,000USD | -1,019,000USD | -25,368,000USD |
| Free Cash Flow | -110,440,000USD | -16,247,000USD | 12,418,000USD | 31,305,000USD | 63,662,000USD | 49,980,000USD | 44,928,000USD | 4,618,000USD |
| Investments | 95,858,000USD | -17,430,000USD | 107,155,000USD | 50,604,000USD | -76,144,000USD | -39,704,000USD | -67,290,000USD | -84,292,000USD |
| Total Cashflows From Investing Activities | 94,860,000USD | -17,430,000USD | -12,056,000USD | 49,925,000USD | -76,696,000USD | -41,499,000USD | -68,309,000USD | -109,660,000USD |
| Net Borrowings | -1,991,000USD | -155,000USD | 0USD | 0USD | — | — | — | — |
| Total Cash From Financing Activities | -2,906,000USD | -155,000USD | 605,000USD | 734,000USD | 3,550,000USD | 5,634,000USD | 6,264,000USD | 107,126,000USD |
| Change In Cash | -17,362,000USD | -33,505,000USD | 792,000USD | 82,958,000USD | -9,017,000USD | 16,016,000USD | -16,033,000USD | 27,414,000USD |
| Begin Period Cash Flow | 102,785,000USD | 136,290,000USD | 135,498,000USD | 52,071,000USD | 61,088,000USD | 45,072,000USD | 61,105,000USD | 34,335,000USD |
| End Period Cash Flow | 85,320,000USD | 102,785,000USD | 136,290,000USD | 135,029,000USD | 52,071,000USD | 61,088,000USD | 45,072,000USD | 61,749,000USD |
| Other Cashflows From Financing Activities | -915,000USD | -155,000USD | -12,056,000USD | 734,000USD | 3,550,000USD | 5,634,000USD | 6,264,000USD | 6,256,000USD |
| Unclassified Operating Cash Flow | 81,443,000USD | -6,482,000USD | -1,286,000USD | 1,130,000USD | 6,745,000USD | 6,189,000USD | -101,225,000USD | -2,221,000USD |
| Other Cashflows From Investing Activities | — | -4,229,000USD | — | 50,604,000USD | 12,000USD | 229,000USD | -67,290,000USD | -25,000,000USD |
| Unclassified Investing Cash Flow | — | 4,719,000USD | -118,828,000USD | -50,604,000USD | — | — | 67,290,000USD | 25,000,000USD |
| Unclassified Financing Cash Flow | — | — | 12,661,000USD | — | -3,550,000USD | -5,634,000USD | -6,264,000USD | -6,256,000USD |
| Change To Liabilities | — | — | — | 11,793,000USD | 3,040,000USD | 3,759,000USD | 3,508,000USD | -618,000USD |
| Sale Purchase Of Stock | — | — | — | 734,000USD | 3,550,000USD | 5,634,000USD | 6,264,000USD | 107,126,000USD |
| Cash And Cash Equivalents Changes | — | — | — | 82,643,000USD | -8,932,000USD | 15,910,000USD | -16,098,000USD | 27,452,000USD |
| Issuance Of Capital Stock | — | — | — | — | — | 0USD | 0USD | 100,870,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| Q2 2026Quarterly · 2026-06-30 | Product | Fanapt | 35,989,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Product | Hetlioz | 5,576,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Product | NEREUS | 1,029,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Product | PONVORY | 7,935,000 | USD | Disclosure |
| Q1 2026Quarterly · 2026-03-31 | Product | Fanapt | 29,560,000 | USD | 0001628280-26-031667 |
| Q1 2026Quarterly · 2026-03-31 | Product | Hetlioz | 15,947,000 | USD | 0001628280-26-031667 |
| Q1 2026Quarterly · 2026-03-31 | Product | PONVORY | 6,211,000 | USD | 0001628280-26-031667 |
| Q4 2025Quarterly · 2025-12-31 | Product | Fanapt | 33,218,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Product | Hetlioz | 16,389,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Product | PONVORY | 7,609,000 | USD | Legacy provider |
| FY 2025Yearly · 2025-12-31 | Product | Fanapt | 117,302,000 | USD | 0001628280-26-007460 |
| FY 2025Yearly · 2025-12-31 | Product | Hetlioz | 71,431,000 | USD | 0001628280-26-007460 |
| FY 2025Yearly · 2025-12-31 | Product | PONVORY | 27,372,000 | USD | 0001628280-26-007460 |
| Q3 2025Quarterly · 2025-09-30 | Product | Fanapt | 31,245,000 | USD | 0001628280-25-047317 |
| Q3 2025Quarterly · 2025-09-30 | Product | Hetlioz | 17,978,000 | USD | 0001628280-25-047317 |
| Q3 2025Quarterly · 2025-09-30 | Product | PONVORY | 7,035,000 | USD | 0001628280-25-047317 |
| Q2 2025Quarterly · 2025-06-30 | Product | Fanapt | 29,294,000 | USD | 0001628280-25-036861 |
| Q2 2025Quarterly · 2025-06-30 | Product | Hetlioz | 16,192,000 | USD | 0001628280-25-036861 |
| Q2 2025Quarterly · 2025-06-30 | Product | PONVORY | 7,104,000 | USD | 0001628280-25-036861 |
| Q1 2025Quarterly · 2025-03-31 | Product | Fanapt | 23,545,000 | USD | 0001628280-26-031667 |
| Q1 2025Quarterly · 2025-03-31 | Product | Hetlioz | 20,872,000 | USD | 0001628280-26-031667 |
| Q1 2025Quarterly · 2025-03-31 | Product | PONVORY | 5,624,000 | USD | 0001628280-26-031667 |
| Q4 2024Quarterly · 2024-12-31 | Product | Fanapt | 26,649,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Product | Hetlioz | 20,044,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Product | PONVORY | 6,492,000 | USD | Legacy provider |
| FY 2024Yearly · 2024-12-31 | Product | Fanapt | 94,297,000 | USD | 0001628280-26-007460 |
| FY 2024Yearly · 2024-12-31 | Product | Hetlioz | 76,675,000 | USD | 0001628280-26-007460 |
| FY 2024Yearly · 2024-12-31 | Product | PONVORY | 27,800,000 | USD | 0001628280-26-007460 |
| Q3 2024Quarterly · 2024-09-30 | Product | Fanapt | 23,919,000 | USD | 0001628280-25-047317 |
| Q3 2024Quarterly · 2024-09-30 | Product | Hetlioz | 17,870,000 | USD | 0001628280-25-047317 |
| Q3 2024Quarterly · 2024-09-30 | Product | PONVORY | 5,862,000 | USD | 0001628280-25-047317 |
| FY 2023Yearly · 2023-12-31 | Product | Fanapt | 90,873,000 | USD | 0001628280-26-007460 |
| FY 2023Yearly · 2023-12-31 | Product | Hetlioz | 100,167,000 | USD | 0001628280-26-007460 |
| FY 2023Yearly · 2023-12-31 | Product | PONVORY | 1,600,000 | USD | 0001628280-26-007460 |
| FY 2022Yearly · 2022-12-31 | Product | Fanapt | 94,727,000 | USD | 0001628280-25-005761 |
| FY 2022Yearly · 2022-12-31 | Product | Hetlioz | 159,655,000 | USD | 0001628280-25-005761 |
| FY 2022Yearly · 2022-12-31 | Product | PONVORY | 0 | USD | 0001628280-25-005761 |
| FY 2021Yearly · 2021-12-31 | Product | Fanapt | 95,146,000 | USD | 0001628280-24-003785 |
| FY 2021Yearly · 2021-12-31 | Product | Hetlioz | 173,536,000 | USD | 0001628280-24-003785 |
| FY 2021Yearly · 2021-12-31 | Product | PONVORY | 0 | USD | 0001628280-24-003785 |
| FY 2020Yearly · 2020-12-31 | Product | Fanapt | 87,482,000 | USD | 0001628280-23-002857 |
| FY 2020Yearly · 2020-12-31 | Product | Hetlioz | 160,686,000 | USD | 0001628280-23-002857 |
| FY 2019Yearly · 2019-12-31 | Product | Fanapt | 84,208,000 | USD | 0001628280-22-003629 |
| FY 2019Yearly · 2019-12-31 | Product | Hetlioz | 142,980,000 | USD | 0001628280-22-003629 |
| FY 2018Yearly · 2018-12-31 | Product | Fanapt | 77,283,000 | USD | 0001347178-21-000005 |
| FY 2018Yearly · 2018-12-31 | Product | Hetlioz | 115,835,000 | USD | 0001347178-21-000005 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.